289 related articles for article (PubMed ID: 26720073)
1. Psychotic Experiences and Neuropsychological Functioning in a Population-based Sample.
Mollon J; David AS; Morgan C; Frissa S; Glahn D; Pilecka I; Hatch SL; Hotopf M; Reichenberg A
JAMA Psychiatry; 2016 Feb; 73(2):129-38. PubMed ID: 26720073
[TBL] [Abstract][Full Text] [Related]
2. Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum.
Mollon J; David AS; Zammit S; Lewis G; Reichenberg A
JAMA Psychiatry; 2018 Mar; 75(3):270-279. PubMed ID: 29387877
[TBL] [Abstract][Full Text] [Related]
3. Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.
Fett AJ; Velthorst E; Reichenberg A; Ruggero CJ; Callahan JL; Fochtmann LJ; Carlson GA; Perlman G; Bromet EJ; Kotov R
JAMA Psychiatry; 2020 Apr; 77(4):387-396. PubMed ID: 31825511
[TBL] [Abstract][Full Text] [Related]
4. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
5. The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression.
Che AM; Gomez RG; Keller J; Lembke A; Tennakoon L; Cohen GH; Schatzberg AF
Psychiatry Res; 2012 Jun; 198(1):34-8. PubMed ID: 22410589
[TBL] [Abstract][Full Text] [Related]
6. No sex differences in neuropsychological performance in first episode psychosis patients.
Ayesa-Arriola R; Rodriguez-Sanchez JM; Gomez-Ruiz E; Roiz-Santiáñez R; Reeves LL; Crespo-Facorro B
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():149-54. PubMed ID: 24075821
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Deficiency Associated With Cognitive Functioning in Psychotic Disorders.
Nerhus M; Berg AO; Simonsen C; Haram M; Haatveit B; Dahl SR; Gurholt TP; Bjella TD; Ueland T; Andreassen OA; Melle I
J Clin Psychiatry; 2017 Jul; 78(7):e750-e757. PubMed ID: 28493652
[TBL] [Abstract][Full Text] [Related]
8. Working memory as a predictor of negative symptoms and functional outcome in first episode psychosis.
González-Ortega I; de Los Mozos V; Echeburúa E; Mezo M; Besga A; Ruiz de Azúa S; González-Pinto A; Gutierrez M; Zorrilla I; González-Pinto A
Psychiatry Res; 2013 Mar; 206(1):8-16. PubMed ID: 22985548
[TBL] [Abstract][Full Text] [Related]
9. Is deterioration of IQ a feature of first episode psychosis and how can we measure it?
O'Connor JA; Wiffen BD; Reichenberg A; Aas M; Falcone MA; Russo M; Sood PG; Taylor H; David AS
Schizophr Res; 2012 May; 137(1-3):104-9. PubMed ID: 22341899
[TBL] [Abstract][Full Text] [Related]
10. Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings.
Velthorst E; Mollon J; Murray RM; de Haan L; Germeys IM; Glahn DC; Arango C; van der Ven E; Di Forti M; Bernardo M; Guloksuz S; Delespaul P; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Santos JL; Jiménez-López E; Sanjuan J; Aguilar EJ; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Atbaşoğlu C; Saka MC; Üçok A; Alptekin K; Akdede B; Binbay T; Altınyazar V; Ulaş H; Yalınçetin B; Gümüş-Akay G; Beyaz BC; Soygür H; Cankurtaran EŞ; Kaymak SU; Maric NP; Mihaljevic MM; Petrovic SA; Mirjanic T; Del-Ben CM; Ferraro L; Gayer-Anderson C; Jones PB; Jongsma HE; Kirkbride JB; La Cascia C; Lasalvia A; Tosato S; Llorca PM; Menezes PR; Morgan C; Quattrone D; Menchetti M; Selten JP; Szöke A; Tarricone I; Tortelli A; McGuire P; Valmaggia L; Kempton MJ; van der Gaag M; Riecher-Rössler A; Bressan RA; Barrantes-Vidal N; Nelson B; McGorry P; Pantelis C; Krebs MO; Ruhrmann S; Sachs G; Rutten BPF; van Os J; Alizadeh BZ; van Amelsvoort T; Bartels-Velthuis AA; Bruggeman R; van Beveren NJ; Luykx JJ; Cahn W; Simons CJP; Kahn RS; Schirmbeck F; van Winkel R; ; Reichenberg A
Mol Psychiatry; 2021 Aug; 26(8):4529-4543. PubMed ID: 33414498
[TBL] [Abstract][Full Text] [Related]
11. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
[TBL] [Abstract][Full Text] [Related]
12. Memory Impairments and Psychosis Prediction: A Scoping Review and Theoretical Overview.
Seabury RD; Cannon TD
Neuropsychol Rev; 2020 Dec; 30(4):521-545. PubMed ID: 33226539
[TBL] [Abstract][Full Text] [Related]
13. Loneliness in psychotic disorders and its association with cognitive function and symptom profile.
Badcock JC; Shah S; Mackinnon A; Stain HJ; Galletly C; Jablensky A; Morgan VA
Schizophr Res; 2015 Dec; 169(1-3):268-273. PubMed ID: 26527247
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis.
Pukrop R; Ruhrmann S; Schultze-Lutter F; Bechdolf A; Brockhaus-Dumke A; Klosterkötter J
Schizophr Res; 2007 May; 92(1-3):116-25. PubMed ID: 17344028
[TBL] [Abstract][Full Text] [Related]
15. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
16. The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together.
Knowles EE; Weiser M; David AS; Glahn DC; Davidson M; Reichenberg A
Biol Psychiatry; 2015 Dec; 78(11):786-93. PubMed ID: 25863361
[TBL] [Abstract][Full Text] [Related]
17. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
Koppel J; Goldberg TE; Gordon ML; Huey E; Davies P; Keehlisen L; Huet S; Christen E; Greenwald BS
Am J Geriatr Psychiatry; 2012 Nov; 20(11):994-1000. PubMed ID: 22048323
[TBL] [Abstract][Full Text] [Related]
18. Serum level of venlafaxine is associated with better memory in psychotic disorders.
Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Vaskinn A; Spigset O; Andreassen OA
Schizophr Res; 2015 Dec; 169(1-3):386-392. PubMed ID: 26516101
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive impairment in bipolar patients with and without history of psychosis.
Martinez-Aran A; Torrent C; Tabares-Seisdedos R; Salamero M; Daban C; Balanza-Martinez V; Sanchez-Moreno J; Manuel Goikolea J; Benabarre A; Colom F; Vieta E
J Clin Psychiatry; 2008 Feb; 69(2):233-9. PubMed ID: 18232725
[TBL] [Abstract][Full Text] [Related]
20. Neurocognition in the extended psychosis phenotype: performance of a community sample of adolescents with psychotic symptoms on the MATRICS neurocognitive battery.
Kelleher I; Clarke MC; Rawdon C; Murphy J; Cannon M
Schizophr Bull; 2013 Sep; 39(5):1018-26. PubMed ID: 22927672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
